nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGB3—prostate cancer	0.696	1	CbGaD
Tirofiban—ITGB3—prostate gland—prostate cancer	0.00969	0.194	CbGeAlD
Tirofiban—ITGB3—epithelium—prostate cancer	0.00712	0.143	CbGeAlD
Tirofiban—ITGB3—renal system—prostate cancer	0.00661	0.132	CbGeAlD
Tirofiban—ITGA2B—bone marrow—prostate cancer	0.00572	0.114	CbGeAlD
Tirofiban—ITGB3—bone marrow—prostate cancer	0.005	0.1	CbGeAlD
Tirofiban—ITGA2B—testis—prostate cancer	0.00489	0.0979	CbGeAlD
Tirofiban—ITGB3—testis—prostate cancer	0.00427	0.0855	CbGeAlD
Tirofiban—ITGA2B—lymph node—prostate cancer	0.00354	0.0709	CbGeAlD
Tirofiban—ITGB3—lymph node—prostate cancer	0.0031	0.062	CbGeAlD
Tirofiban—Sweating—Bicalutamide—prostate cancer	0.000567	0.00671	CcSEcCtD
Tirofiban—Haematuria—Bicalutamide—prostate cancer	0.000564	0.00667	CcSEcCtD
Tirofiban—Oedema—Estrone—prostate cancer	0.000563	0.00665	CcSEcCtD
Tirofiban—Anaphylactic shock—Estrone—prostate cancer	0.000563	0.00665	CcSEcCtD
Tirofiban—Chills—Cabazitaxel—prostate cancer	0.000556	0.00657	CcSEcCtD
Tirofiban—Hypertension—Nilutamide—prostate cancer	0.000553	0.00654	CcSEcCtD
Tirofiban—Hypertension—Flutamide—prostate cancer	0.000551	0.00651	CcSEcCtD
Tirofiban—Haemoglobin decreased—Docetaxel—prostate cancer	0.000546	0.00645	CcSEcCtD
Tirofiban—Bradycardia—Bicalutamide—prostate cancer	0.000541	0.00639	CcSEcCtD
Tirofiban—Haemoglobin—Bicalutamide—prostate cancer	0.000534	0.00631	CcSEcCtD
Tirofiban—Haemorrhage—Bicalutamide—prostate cancer	0.000531	0.00628	CcSEcCtD
Tirofiban—Haemoglobin decreased—Capecitabine—prostate cancer	0.000529	0.00625	CcSEcCtD
Tirofiban—Haematemesis—Capecitabine—prostate cancer	0.000524	0.00619	CcSEcCtD
Tirofiban—Oedema—Nilutamide—prostate cancer	0.000523	0.00618	CcSEcCtD
Tirofiban—Oedema—Flutamide—prostate cancer	0.000521	0.00615	CcSEcCtD
Tirofiban—Thrombocytopenia—Flutamide—prostate cancer	0.00051	0.00602	CcSEcCtD
Tirofiban—Hyperhidrosis—Nilutamide—prostate cancer	0.000505	0.00597	CcSEcCtD
Tirofiban—Hypertension—Degarelix—prostate cancer	0.000494	0.00584	CcSEcCtD
Tirofiban—Haemoptysis—Capecitabine—prostate cancer	0.000492	0.00581	CcSEcCtD
Tirofiban—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000491	0.00581	CcSEcCtD
Tirofiban—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.000491	0.00581	CcSEcCtD
Tirofiban—Myocardial infarction—Ethinyl Estradiol—prostate cancer	0.00049	0.0058	CcSEcCtD
Tirofiban—Pain—Estrone—prostate cancer	0.000481	0.00569	CcSEcCtD
Tirofiban—Swelling—Estradiol—prostate cancer	0.00048	0.00567	CcSEcCtD
Tirofiban—Chills—Bicalutamide—prostate cancer	0.000477	0.00563	CcSEcCtD
Tirofiban—Anaphylactic shock—Degarelix—prostate cancer	0.000467	0.00552	CcSEcCtD
Tirofiban—Hypertension—Cabazitaxel—prostate cancer	0.000465	0.0055	CcSEcCtD
Tirofiban—Body temperature increased—Abiraterone—prostate cancer	0.000452	0.00535	CcSEcCtD
Tirofiban—Hyperhidrosis—Degarelix—prostate cancer	0.000452	0.00534	CcSEcCtD
Tirofiban—Haemoglobin—Ethinyl Estradiol—prostate cancer	0.000451	0.00533	CcSEcCtD
Tirofiban—Haemorrhage—Ethinyl Estradiol—prostate cancer	0.000449	0.00531	CcSEcCtD
Tirofiban—Swelling—Mitoxantrone—prostate cancer	0.000447	0.00529	CcSEcCtD
Tirofiban—Urticaria—Estrone—prostate cancer	0.000447	0.00529	CcSEcCtD
Tirofiban—Pain—Nilutamide—prostate cancer	0.000447	0.00528	CcSEcCtD
Tirofiban—Oedema—Cabazitaxel—prostate cancer	0.00044	0.0052	CcSEcCtD
Tirofiban—Thrombocytopenia—Cabazitaxel—prostate cancer	0.000431	0.00509	CcSEcCtD
Tirofiban—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00042	0.00497	CcSEcCtD
Tirofiban—Body temperature increased—Nilutamide—prostate cancer	0.000413	0.00489	CcSEcCtD
Tirofiban—Myocardial infarction—Goserelin—prostate cancer	0.000404	0.00477	CcSEcCtD
Tirofiban—Myocardial infarction—Conjugated Estrogens—prostate cancer	0.0004	0.00472	CcSEcCtD
Tirofiban—Pain—Degarelix—prostate cancer	0.000399	0.00472	CcSEcCtD
Tirofiban—Hypertension—Bicalutamide—prostate cancer	0.000399	0.00472	CcSEcCtD
Tirofiban—Sweating—Goserelin—prostate cancer	0.000395	0.00467	CcSEcCtD
Tirofiban—Haematuria—Goserelin—prostate cancer	0.000393	0.00464	CcSEcCtD
Tirofiban—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.00039	0.00461	CcSEcCtD
Tirofiban—Oedema—Bicalutamide—prostate cancer	0.000377	0.00446	CcSEcCtD
Tirofiban—Pain—Cabazitaxel—prostate cancer	0.000376	0.00445	CcSEcCtD
Tirofiban—Dizziness—Estrone—prostate cancer	0.000372	0.0044	CcSEcCtD
Tirofiban—Swelling—Etoposide—prostate cancer	0.000372	0.0044	CcSEcCtD
Tirofiban—Haemoglobin—Goserelin—prostate cancer	0.000371	0.00439	CcSEcCtD
Tirofiban—Urticaria—Degarelix—prostate cancer	0.000371	0.00439	CcSEcCtD
Tirofiban—Haemorrhage—Goserelin—prostate cancer	0.00037	0.00437	CcSEcCtD
Tirofiban—Thrombocytopenia—Bicalutamide—prostate cancer	0.00037	0.00437	CcSEcCtD
Tirofiban—Body temperature increased—Degarelix—prostate cancer	0.000369	0.00436	CcSEcCtD
Tirofiban—Headache—Estramustine—prostate cancer	0.000369	0.00436	CcSEcCtD
Tirofiban—Hyperhidrosis—Bicalutamide—prostate cancer	0.000365	0.00431	CcSEcCtD
Tirofiban—Haematemesis—Epirubicin—prostate cancer	0.000365	0.00431	CcSEcCtD
Tirofiban—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000362	0.00428	CcSEcCtD
Tirofiban—Headache—Estrone—prostate cancer	0.000353	0.00417	CcSEcCtD
Tirofiban—Nausea—Estramustine—prostate cancer	0.00035	0.00414	CcSEcCtD
Tirofiban—Body temperature increased—Cabazitaxel—prostate cancer	0.000348	0.00411	CcSEcCtD
Tirofiban—Dizziness—Nilutamide—prostate cancer	0.000346	0.00409	CcSEcCtD
Tirofiban—Dizziness—Flutamide—prostate cancer	0.000344	0.00407	CcSEcCtD
Tirofiban—Hypersensitivity—Degarelix—prostate cancer	0.000344	0.00407	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Prednisone—prostate cancer	0.000343	0.00405	CcSEcCtD
Tirofiban—Haemoptysis—Epirubicin—prostate cancer	0.000342	0.00405	CcSEcCtD
Tirofiban—Haematemesis—Doxorubicin—prostate cancer	0.000338	0.00399	CcSEcCtD
Tirofiban—Nausea—Estrone—prostate cancer	0.000334	0.00395	CcSEcCtD
Tirofiban—Chills—Goserelin—prostate cancer	0.000332	0.00392	CcSEcCtD
Tirofiban—Headache—Nilutamide—prostate cancer	0.000328	0.00387	CcSEcCtD
Tirofiban—Headache—Flutamide—prostate cancer	0.000326	0.00385	CcSEcCtD
Tirofiban—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000325	0.00384	CcSEcCtD
Tirofiban—Hypersensitivity—Cabazitaxel—prostate cancer	0.000324	0.00383	CcSEcCtD
Tirofiban—Pain—Bicalutamide—prostate cancer	0.000323	0.00382	CcSEcCtD
Tirofiban—Myocardial infarction—Estradiol—prostate cancer	0.00032	0.00378	CcSEcCtD
Tirofiban—Oedema—Ethinyl Estradiol—prostate cancer	0.000319	0.00377	CcSEcCtD
Tirofiban—Haemoptysis—Doxorubicin—prostate cancer	0.000317	0.00375	CcSEcCtD
Tirofiban—Haematuria—Estradiol—prostate cancer	0.000311	0.00368	CcSEcCtD
Tirofiban—Nausea—Nilutamide—prostate cancer	0.000311	0.00367	CcSEcCtD
Tirofiban—Swelling—Docetaxel—prostate cancer	0.000309	0.00365	CcSEcCtD
Tirofiban—Nausea—Flutamide—prostate cancer	0.000309	0.00365	CcSEcCtD
Tirofiban—Dizziness—Degarelix—prostate cancer	0.000309	0.00365	CcSEcCtD
Tirofiban—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000308	0.00364	CcSEcCtD
Tirofiban—Urticaria—Bicalutamide—prostate cancer	0.0003	0.00354	CcSEcCtD
Tirofiban—Swelling—Capecitabine—prostate cancer	0.000299	0.00354	CcSEcCtD
Tirofiban—Body temperature increased—Bicalutamide—prostate cancer	0.000298	0.00353	CcSEcCtD
Tirofiban—Myocardial infarction—Mitoxantrone—prostate cancer	0.000298	0.00352	CcSEcCtD
Tirofiban—Haemoglobin—Estradiol—prostate cancer	0.000294	0.00348	CcSEcCtD
Tirofiban—Haemorrhage—Estradiol—prostate cancer	0.000293	0.00346	CcSEcCtD
Tirofiban—Headache—Degarelix—prostate cancer	0.000293	0.00346	CcSEcCtD
Tirofiban—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000292	0.00345	CcSEcCtD
Tirofiban—Sweating—Mitoxantrone—prostate cancer	0.000292	0.00345	CcSEcCtD
Tirofiban—Dizziness—Cabazitaxel—prostate cancer	0.000291	0.00344	CcSEcCtD
Tirofiban—Haematuria—Mitoxantrone—prostate cancer	0.00029	0.00343	CcSEcCtD
Tirofiban—Hypersensitivity—Bicalutamide—prostate cancer	0.000278	0.00329	CcSEcCtD
Tirofiban—Bradycardia—Mitoxantrone—prostate cancer	0.000278	0.00328	CcSEcCtD
Tirofiban—Hypertension—Goserelin—prostate cancer	0.000278	0.00328	CcSEcCtD
Tirofiban—Nausea—Degarelix—prostate cancer	0.000277	0.00328	CcSEcCtD
Tirofiban—Headache—Cabazitaxel—prostate cancer	0.000276	0.00326	CcSEcCtD
Tirofiban—Haemoglobin—Mitoxantrone—prostate cancer	0.000274	0.00324	CcSEcCtD
Tirofiban—Haemorrhage—Mitoxantrone—prostate cancer	0.000273	0.00323	CcSEcCtD
Tirofiban—Chills—Estradiol—prostate cancer	0.000263	0.00311	CcSEcCtD
Tirofiban—Anaphylactic shock—Goserelin—prostate cancer	0.000263	0.0031	CcSEcCtD
Tirofiban—Oedema—Goserelin—prostate cancer	0.000263	0.0031	CcSEcCtD
Tirofiban—Nausea—Cabazitaxel—prostate cancer	0.000261	0.00309	CcSEcCtD
Tirofiban—Oedema—Conjugated Estrogens—prostate cancer	0.00026	0.00307	CcSEcCtD
Tirofiban—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00026	0.00307	CcSEcCtD
Tirofiban—Thrombocytopenia—Goserelin—prostate cancer	0.000257	0.00304	CcSEcCtD
Tirofiban—Hyperhidrosis—Goserelin—prostate cancer	0.000254	0.003	CcSEcCtD
Tirofiban—Urticaria—Ethinyl Estradiol—prostate cancer	0.000253	0.003	CcSEcCtD
Tirofiban—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000252	0.00298	CcSEcCtD
Tirofiban—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000251	0.00297	CcSEcCtD
Tirofiban—Dizziness—Bicalutamide—prostate cancer	0.00025	0.00295	CcSEcCtD
Tirofiban—Myocardial infarction—Etoposide—prostate cancer	0.000248	0.00293	CcSEcCtD
Tirofiban—Chills—Mitoxantrone—prostate cancer	0.000245	0.0029	CcSEcCtD
Tirofiban—Headache—Bicalutamide—prostate cancer	0.000236	0.00279	CcSEcCtD
Tirofiban—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000235	0.00278	CcSEcCtD
Tirofiban—Pain—Goserelin—prostate cancer	0.000225	0.00265	CcSEcCtD
Tirofiban—Nausea—Bicalutamide—prostate cancer	0.000224	0.00265	CcSEcCtD
Tirofiban—Pain—Conjugated Estrogens—prostate cancer	0.000222	0.00263	CcSEcCtD
Tirofiban—Hypertension—Estradiol—prostate cancer	0.00022	0.0026	CcSEcCtD
Tirofiban—Dizziness—Ethinyl Estradiol—prostate cancer	0.000211	0.00249	CcSEcCtD
Tirofiban—Urticaria—Goserelin—prostate cancer	0.000209	0.00247	CcSEcCtD
Tirofiban—Anaphylactic shock—Estradiol—prostate cancer	0.000208	0.00246	CcSEcCtD
Tirofiban—Oedema—Estradiol—prostate cancer	0.000208	0.00246	CcSEcCtD
Tirofiban—Body temperature increased—Goserelin—prostate cancer	0.000208	0.00245	CcSEcCtD
Tirofiban—Urticaria—Conjugated Estrogens—prostate cancer	0.000207	0.00244	CcSEcCtD
Tirofiban—Myocardial infarction—Docetaxel—prostate cancer	0.000206	0.00244	CcSEcCtD
Tirofiban—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000206	0.00243	CcSEcCtD
Tirofiban—Hypertension—Mitoxantrone—prostate cancer	0.000205	0.00243	CcSEcCtD
Tirofiban—Chills—Etoposide—prostate cancer	0.000204	0.00241	CcSEcCtD
Tirofiban—Hyperhidrosis—Estradiol—prostate cancer	0.000201	0.00238	CcSEcCtD
Tirofiban—Headache—Ethinyl Estradiol—prostate cancer	0.0002	0.00236	CcSEcCtD
Tirofiban—Myocardial infarction—Capecitabine—prostate cancer	0.0002	0.00236	CcSEcCtD
Tirofiban—Haematuria—Capecitabine—prostate cancer	0.000194	0.00229	CcSEcCtD
Tirofiban—Oedema—Mitoxantrone—prostate cancer	0.000194	0.00229	CcSEcCtD
Tirofiban—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000194	0.00229	CcSEcCtD
Tirofiban—Hypersensitivity—Goserelin—prostate cancer	0.000193	0.00229	CcSEcCtD
Tirofiban—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000192	0.00226	CcSEcCtD
Tirofiban—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00019	0.00224	CcSEcCtD
Tirofiban—Haemoglobin—Docetaxel—prostate cancer	0.00019	0.00224	CcSEcCtD
Tirofiban—Nausea—Ethinyl Estradiol—prostate cancer	0.00019	0.00224	CcSEcCtD
Tirofiban—Haemorrhage—Docetaxel—prostate cancer	0.000189	0.00223	CcSEcCtD
Tirofiban—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000187	0.00222	CcSEcCtD
Tirofiban—Bradycardia—Capecitabine—prostate cancer	0.000186	0.0022	CcSEcCtD
Tirofiban—Haemoglobin—Capecitabine—prostate cancer	0.000184	0.00217	CcSEcCtD
Tirofiban—Haemorrhage—Capecitabine—prostate cancer	0.000183	0.00216	CcSEcCtD
Tirofiban—Pain—Estradiol—prostate cancer	0.000178	0.0021	CcSEcCtD
Tirofiban—Myocardial infarction—Prednisone—prostate cancer	0.000178	0.0021	CcSEcCtD
Tirofiban—Dizziness—Goserelin—prostate cancer	0.000174	0.00205	CcSEcCtD
Tirofiban—Dizziness—Conjugated Estrogens—prostate cancer	0.000172	0.00203	CcSEcCtD
Tirofiban—Hypertension—Etoposide—prostate cancer	0.000171	0.00202	CcSEcCtD
Tirofiban—Chills—Docetaxel—prostate cancer	0.000169	0.002	CcSEcCtD
Tirofiban—Pain—Mitoxantrone—prostate cancer	0.000166	0.00196	CcSEcCtD
Tirofiban—Bradycardia—Prednisone—prostate cancer	0.000166	0.00196	CcSEcCtD
Tirofiban—Urticaria—Estradiol—prostate cancer	0.000165	0.00195	CcSEcCtD
Tirofiban—Body temperature increased—Estradiol—prostate cancer	0.000165	0.00194	CcSEcCtD
Tirofiban—Headache—Goserelin—prostate cancer	0.000164	0.00194	CcSEcCtD
Tirofiban—Chills—Capecitabine—prostate cancer	0.000164	0.00194	CcSEcCtD
Tirofiban—Haemoglobin—Prednisone—prostate cancer	0.000164	0.00193	CcSEcCtD
Tirofiban—Headache—Conjugated Estrogens—prostate cancer	0.000163	0.00193	CcSEcCtD
Tirofiban—Haemorrhage—Prednisone—prostate cancer	0.000163	0.00192	CcSEcCtD
Tirofiban—Anaphylactic shock—Etoposide—prostate cancer	0.000161	0.00191	CcSEcCtD
Tirofiban—Thrombocytopenia—Etoposide—prostate cancer	0.000158	0.00187	CcSEcCtD
Tirofiban—Nausea—Goserelin—prostate cancer	0.000156	0.00184	CcSEcCtD
Tirofiban—Hyperhidrosis—Etoposide—prostate cancer	0.000156	0.00184	CcSEcCtD
Tirofiban—Nausea—Conjugated Estrogens—prostate cancer	0.000154	0.00183	CcSEcCtD
Tirofiban—Urticaria—Mitoxantrone—prostate cancer	0.000154	0.00182	CcSEcCtD
Tirofiban—Hypersensitivity—Estradiol—prostate cancer	0.000153	0.00181	CcSEcCtD
Tirofiban—Body temperature increased—Mitoxantrone—prostate cancer	0.000153	0.00181	CcSEcCtD
Tirofiban—Hypersensitivity—Mitoxantrone—prostate cancer	0.000143	0.00169	CcSEcCtD
Tirofiban—Hypertension—Docetaxel—prostate cancer	0.000142	0.00168	CcSEcCtD
Tirofiban—Pain—Etoposide—prostate cancer	0.000138	0.00163	CcSEcCtD
Tirofiban—Dizziness—Estradiol—prostate cancer	0.000138	0.00163	CcSEcCtD
Tirofiban—Hypertension—Capecitabine—prostate cancer	0.000137	0.00162	CcSEcCtD
Tirofiban—Sweating—Epirubicin—prostate cancer	0.000136	0.00161	CcSEcCtD
Tirofiban—Haematuria—Epirubicin—prostate cancer	0.000135	0.0016	CcSEcCtD
Tirofiban—Oedema—Docetaxel—prostate cancer	0.000134	0.00158	CcSEcCtD
Tirofiban—Anaphylactic shock—Docetaxel—prostate cancer	0.000134	0.00158	CcSEcCtD
Tirofiban—Thrombocytopenia—Docetaxel—prostate cancer	0.000131	0.00155	CcSEcCtD
Tirofiban—Headache—Estradiol—prostate cancer	0.00013	0.00154	CcSEcCtD
Tirofiban—Oedema—Capecitabine—prostate cancer	0.00013	0.00153	CcSEcCtD
Tirofiban—Bradycardia—Epirubicin—prostate cancer	0.00013	0.00153	CcSEcCtD
Tirofiban—Urticaria—Etoposide—prostate cancer	0.000128	0.00151	CcSEcCtD
Tirofiban—Haemoglobin—Epirubicin—prostate cancer	0.000128	0.00151	CcSEcCtD
Tirofiban—Body temperature increased—Etoposide—prostate cancer	0.000128	0.00151	CcSEcCtD
Tirofiban—Haemorrhage—Epirubicin—prostate cancer	0.000127	0.0015	CcSEcCtD
Tirofiban—Thrombocytopenia—Capecitabine—prostate cancer	0.000127	0.0015	CcSEcCtD
Tirofiban—Sweating—Doxorubicin—prostate cancer	0.000126	0.00149	CcSEcCtD
Tirofiban—Hyperhidrosis—Capecitabine—prostate cancer	0.000125	0.00148	CcSEcCtD
Tirofiban—Haematuria—Doxorubicin—prostate cancer	0.000125	0.00148	CcSEcCtD
Tirofiban—Nausea—Estradiol—prostate cancer	0.000124	0.00146	CcSEcCtD
Tirofiban—Hypertension—Prednisone—prostate cancer	0.000122	0.00145	CcSEcCtD
Tirofiban—Headache—Mitoxantrone—prostate cancer	0.000122	0.00144	CcSEcCtD
Tirofiban—Bradycardia—Doxorubicin—prostate cancer	0.00012	0.00142	CcSEcCtD
Tirofiban—Hypersensitivity—Etoposide—prostate cancer	0.000119	0.0014	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—prostate cancer	0.000118	0.0014	CcSEcCtD
Tirofiban—Haemorrhage—Doxorubicin—prostate cancer	0.000118	0.00139	CcSEcCtD
Tirofiban—Anaphylactic shock—Prednisone—prostate cancer	0.000116	0.00137	CcSEcCtD
Tirofiban—Oedema—Prednisone—prostate cancer	0.000116	0.00137	CcSEcCtD
Tirofiban—Nausea—Mitoxantrone—prostate cancer	0.000115	0.00136	CcSEcCtD
Tirofiban—Pain—Docetaxel—prostate cancer	0.000115	0.00136	CcSEcCtD
Tirofiban—Chills—Epirubicin—prostate cancer	0.000114	0.00135	CcSEcCtD
Tirofiban—Hyperhidrosis—Prednisone—prostate cancer	0.000112	0.00132	CcSEcCtD
Tirofiban—Pain—Capecitabine—prostate cancer	0.000111	0.00131	CcSEcCtD
Tirofiban—Dizziness—Etoposide—prostate cancer	0.000107	0.00126	CcSEcCtD
Tirofiban—Body temperature increased—Docetaxel—prostate cancer	0.000106	0.00125	CcSEcCtD
Tirofiban—Chills—Doxorubicin—prostate cancer	0.000106	0.00125	CcSEcCtD
Tirofiban—Urticaria—Capecitabine—prostate cancer	0.000103	0.00122	CcSEcCtD
Tirofiban—Body temperature increased—Capecitabine—prostate cancer	0.000103	0.00121	CcSEcCtD
Tirofiban—Headache—Etoposide—prostate cancer	0.000101	0.00119	CcSEcCtD
Tirofiban—Hypersensitivity—Docetaxel—prostate cancer	9.88e-05	0.00117	CcSEcCtD
Tirofiban—Nausea—Etoposide—prostate cancer	9.58e-05	0.00113	CcSEcCtD
Tirofiban—Hypertension—Epirubicin—prostate cancer	9.57e-05	0.00113	CcSEcCtD
Tirofiban—Hypersensitivity—Capecitabine—prostate cancer	9.56e-05	0.00113	CcSEcCtD
Tirofiban—Urticaria—Prednisone—prostate cancer	9.19e-05	0.00109	CcSEcCtD
Tirofiban—Body temperature increased—Prednisone—prostate cancer	9.14e-05	0.00108	CcSEcCtD
Tirofiban—Anaphylactic shock—Epirubicin—prostate cancer	9.04e-05	0.00107	CcSEcCtD
Tirofiban—Oedema—Epirubicin—prostate cancer	9.04e-05	0.00107	CcSEcCtD
Tirofiban—Dizziness—Docetaxel—prostate cancer	8.87e-05	0.00105	CcSEcCtD
Tirofiban—Thrombocytopenia—Epirubicin—prostate cancer	8.85e-05	0.00105	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—prostate cancer	8.85e-05	0.00105	CcSEcCtD
Tirofiban—Hyperhidrosis—Epirubicin—prostate cancer	8.74e-05	0.00103	CcSEcCtD
Tirofiban—Dizziness—Capecitabine—prostate cancer	8.58e-05	0.00101	CcSEcCtD
Tirofiban—Hypersensitivity—Prednisone—prostate cancer	8.52e-05	0.00101	CcSEcCtD
Tirofiban—Headache—Docetaxel—prostate cancer	8.4e-05	0.000993	CcSEcCtD
Tirofiban—Anaphylactic shock—Doxorubicin—prostate cancer	8.37e-05	0.000989	CcSEcCtD
Tirofiban—Oedema—Doxorubicin—prostate cancer	8.37e-05	0.000989	CcSEcCtD
Tirofiban—Thrombocytopenia—Doxorubicin—prostate cancer	8.19e-05	0.000968	CcSEcCtD
Tirofiban—Headache—Capecitabine—prostate cancer	8.13e-05	0.000961	CcSEcCtD
Tirofiban—Hyperhidrosis—Doxorubicin—prostate cancer	8.09e-05	0.000956	CcSEcCtD
Tirofiban—Nausea—Docetaxel—prostate cancer	7.96e-05	0.000941	CcSEcCtD
Tirofiban—Pain—Epirubicin—prostate cancer	7.73e-05	0.000914	CcSEcCtD
Tirofiban—Nausea—Capecitabine—prostate cancer	7.71e-05	0.000911	CcSEcCtD
Tirofiban—Dizziness—Prednisone—prostate cancer	7.65e-05	0.000904	CcSEcCtD
Tirofiban—Headache—Prednisone—prostate cancer	7.24e-05	0.000856	CcSEcCtD
Tirofiban—Urticaria—Epirubicin—prostate cancer	7.18e-05	0.000849	CcSEcCtD
Tirofiban—Pain—Doxorubicin—prostate cancer	7.16e-05	0.000846	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—prostate cancer	7.15e-05	0.000845	CcSEcCtD
Tirofiban—Nausea—Prednisone—prostate cancer	6.87e-05	0.000812	CcSEcCtD
Tirofiban—Hypersensitivity—Epirubicin—prostate cancer	6.66e-05	0.000788	CcSEcCtD
Tirofiban—Urticaria—Doxorubicin—prostate cancer	6.65e-05	0.000786	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—prostate cancer	6.61e-05	0.000782	CcSEcCtD
Tirofiban—Hypersensitivity—Doxorubicin—prostate cancer	6.16e-05	0.000729	CcSEcCtD
Tirofiban—Dizziness—Epirubicin—prostate cancer	5.98e-05	0.000707	CcSEcCtD
Tirofiban—Headache—Epirubicin—prostate cancer	5.67e-05	0.00067	CcSEcCtD
Tirofiban—Dizziness—Doxorubicin—prostate cancer	5.53e-05	0.000654	CcSEcCtD
Tirofiban—Nausea—Epirubicin—prostate cancer	5.37e-05	0.000635	CcSEcCtD
Tirofiban—Headache—Doxorubicin—prostate cancer	5.24e-05	0.00062	CcSEcCtD
Tirofiban—Nausea—Doxorubicin—prostate cancer	4.97e-05	0.000587	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—MMP9—prostate cancer	3.35e-05	0.000198	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—AKT1—prostate cancer	3.35e-05	0.000198	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—FGF2—prostate cancer	3.33e-05	0.000197	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ERBB2—prostate cancer	3.32e-05	0.000196	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—VEGFA—prostate cancer	3.32e-05	0.000196	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HIST1H2BG—prostate cancer	3.31e-05	0.000196	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KDR—prostate cancer	3.31e-05	0.000196	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—CAV1—prostate cancer	3.29e-05	0.000194	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GRB7—prostate cancer	3.28e-05	0.000194	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDE4D—prostate cancer	3.28e-05	0.000194	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PENK—prostate cancer	3.25e-05	0.000192	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—AKT1—prostate cancer	3.25e-05	0.000192	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NOS3—prostate cancer	3.22e-05	0.000191	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HIST1H4H—prostate cancer	3.2e-05	0.000189	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—JAK2—prostate cancer	3.19e-05	0.000189	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	3.19e-05	0.000188	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—JAK2—prostate cancer	3.13e-05	0.000185	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GNG5—prostate cancer	3.12e-05	0.000185	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GHR—prostate cancer	3.1e-05	0.000183	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—ERBB2—prostate cancer	3.07e-05	0.000182	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—PIK3CA—prostate cancer	3.06e-05	0.000181	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CG—prostate cancer	2.99e-05	0.000177	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—EGFR—prostate cancer	2.99e-05	0.000176	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CB—prostate cancer	2.98e-05	0.000176	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRP1—prostate cancer	2.98e-05	0.000176	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—EGF—prostate cancer	2.96e-05	0.000175	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—GSK3B—prostate cancer	2.93e-05	0.000173	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—INS—prostate cancer	2.89e-05	0.000171	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—AKT1—prostate cancer	2.88e-05	0.00017	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MMP9—prostate cancer	2.85e-05	0.000168	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CREBBP—prostate cancer	2.83e-05	0.000167	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—KRAS—prostate cancer	2.82e-05	0.000167	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—CREBBP—prostate cancer	2.77e-05	0.000164	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VIP—prostate cancer	2.77e-05	0.000163	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GNRH1—prostate cancer	2.77e-05	0.000163	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—TGFB1—prostate cancer	2.76e-05	0.000163	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IGF1—prostate cancer	2.74e-05	0.000162	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IL2—prostate cancer	2.73e-05	0.000162	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTHLH—prostate cancer	2.72e-05	0.000161	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFBR1—prostate cancer	2.72e-05	0.000161	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	2.71e-05	0.00016	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP2—prostate cancer	2.7e-05	0.00016	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAP2K1—prostate cancer	2.7e-05	0.00016	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CTNNB1—prostate cancer	2.69e-05	0.000159	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GRP—prostate cancer	2.68e-05	0.000158	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LPAR1—prostate cancer	2.68e-05	0.000158	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKR1C3—prostate cancer	2.68e-05	0.000158	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PRKACB—prostate cancer	2.66e-05	0.000157	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PLCB2—prostate cancer	2.65e-05	0.000157	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LRP2—prostate cancer	2.65e-05	0.000157	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP9—prostate cancer	2.64e-05	0.000156	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CD—prostate cancer	2.63e-05	0.000155	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—SRC—prostate cancer	2.62e-05	0.000155	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SERPINE1—prostate cancer	2.6e-05	0.000154	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—P4HB—prostate cancer	2.6e-05	0.000154	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CX3CL1—prostate cancer	2.6e-05	0.000154	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—THBS1—prostate cancer	2.6e-05	0.000153	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PPP3CA—prostate cancer	2.6e-05	0.000153	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—FGF2—prostate cancer	2.57e-05	0.000152	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ANXA1—prostate cancer	2.56e-05	0.000151	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—VEGFA—prostate cancer	2.56e-05	0.000151	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HIST1H2BG—prostate cancer	2.55e-05	0.000151	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GRB7—prostate cancer	2.53e-05	0.00015	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDE4D—prostate cancer	2.53e-05	0.00015	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PRKCZ—prostate cancer	2.51e-05	0.000148	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EP300—prostate cancer	2.5e-05	0.000148	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—AKT1—prostate cancer	2.5e-05	0.000148	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NOS3—prostate cancer	2.48e-05	0.000147	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HIST1H4H—prostate cancer	2.47e-05	0.000146	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—JAK2—prostate cancer	2.46e-05	0.000145	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—EP300—prostate cancer	2.45e-05	0.000145	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—SRC—prostate cancer	2.43e-05	0.000144	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGFR4—prostate cancer	2.43e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PARP1—prostate cancer	2.43e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—JAK2—prostate cancer	2.41e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GNG5—prostate cancer	2.41e-05	0.000142	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CALCA—prostate cancer	2.4e-05	0.000142	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SRC—prostate cancer	2.39e-05	0.000141	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ERBB2—prostate cancer	2.37e-05	0.00014	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—prostate cancer	2.37e-05	0.00014	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—STAT3—prostate cancer	2.34e-05	0.000139	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL12—prostate cancer	2.34e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—VEGFA—prostate cancer	2.32e-05	0.000137	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—EGFR—prostate cancer	2.3e-05	0.000136	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—prostate cancer	2.3e-05	0.000136	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CB—prostate cancer	2.29e-05	0.000135	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—AKT1—prostate cancer	2.22e-05	0.000131	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CASP9—prostate cancer	2.2e-05	0.00013	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TGFB1—prostate cancer	2.17e-05	0.000128	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—prostate cancer	2.17e-05	0.000128	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PRKCQ—prostate cancer	2.14e-05	0.000126	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NGFR—prostate cancer	2.14e-05	0.000126	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB1—prostate cancer	2.13e-05	0.000126	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EGFR—prostate cancer	2.13e-05	0.000126	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAP3K7—prostate cancer	2.11e-05	0.000125	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—prostate cancer	2.11e-05	0.000124	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFBR1—prostate cancer	2.1e-05	0.000124	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTHLH—prostate cancer	2.1e-05	0.000124	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CTNNB1—prostate cancer	2.07e-05	0.000122	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKR1C3—prostate cancer	2.06e-05	0.000122	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PRKACB—prostate cancer	2.05e-05	0.000121	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP9—prostate cancer	2.03e-05	0.00012	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF10—prostate cancer	2.03e-05	0.00012	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—KRAS—prostate cancer	2.01e-05	0.000119	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ADRB2—prostate cancer	2.01e-05	0.000119	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PPP3CA—prostate cancer	2e-05	0.000118	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—THBS1—prostate cancer	2e-05	0.000118	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—KRAS—prostate cancer	1.97e-05	0.000117	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ANXA1—prostate cancer	1.97e-05	0.000116	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VAV3—prostate cancer	1.96e-05	0.000116	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PRKCZ—prostate cancer	1.93e-05	0.000114	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFBR2—prostate cancer	1.93e-05	0.000114	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EP300—prostate cancer	1.93e-05	0.000114	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ITPR1—prostate cancer	1.9e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—EP300—prostate cancer	1.89e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—SRC—prostate cancer	1.87e-05	0.000111	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGFR4—prostate cancer	1.87e-05	0.00011	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PARP1—prostate cancer	1.87e-05	0.00011	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CALCA—prostate cancer	1.85e-05	0.000109	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SRC—prostate cancer	1.84e-05	0.000109	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—prostate cancer	1.82e-05	0.000108	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1R—prostate cancer	1.82e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CA—prostate cancer	1.81e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—STAT3—prostate cancer	1.81e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL12—prostate cancer	1.8e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—prostate cancer	1.79e-05	0.000106	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—prostate cancer	1.77e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—prostate cancer	1.76e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LPL—prostate cancer	1.74e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDGFRB—prostate cancer	1.73e-05	0.000102	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CASP9—prostate cancer	1.7e-05	0.0001	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ITGB3—prostate cancer	1.68e-05	9.94e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TGFB1—prostate cancer	1.67e-05	9.89e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PRKCQ—prostate cancer	1.65e-05	9.72e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NGFR—prostate cancer	1.65e-05	9.72e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB1—prostate cancer	1.64e-05	9.71e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EGFR—prostate cancer	1.64e-05	9.7e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—prostate cancer	1.64e-05	9.68e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB3—prostate cancer	1.63e-05	9.64e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGFR2—prostate cancer	1.63e-05	9.62e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAP3K7—prostate cancer	1.63e-05	9.61e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF10—prostate cancer	1.56e-05	9.24e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TERT—prostate cancer	1.56e-05	9.24e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—prostate cancer	1.55e-05	9.16e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ADRB2—prostate cancer	1.55e-05	9.14e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—prostate cancer	1.52e-05	8.99e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—AKT1—prostate cancer	1.51e-05	8.93e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VAV3—prostate cancer	1.51e-05	8.91e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HIF1A—prostate cancer	1.49e-05	8.83e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFBR2—prostate cancer	1.49e-05	8.79e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—AKT1—prostate cancer	1.48e-05	8.76e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ITPR1—prostate cancer	1.46e-05	8.65e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LEP—prostate cancer	1.46e-05	8.62e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CAV1—prostate cancer	1.45e-05	8.54e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KDR—prostate cancer	1.43e-05	8.45e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1R—prostate cancer	1.4e-05	8.27e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CA—prostate cancer	1.4e-05	8.26e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ESR1—prostate cancer	1.39e-05	8.23e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—BAD—prostate cancer	1.36e-05	8.04e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—prostate cancer	1.35e-05	7.99e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LPL—prostate cancer	1.34e-05	7.92e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDGFRB—prostate cancer	1.33e-05	7.85e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—APC—prostate cancer	1.32e-05	7.78e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CG—prostate cancer	1.32e-05	7.78e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IRS1—prostate cancer	1.3e-05	7.69e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGF—prostate cancer	1.3e-05	7.69e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GSK3B—prostate cancer	1.26e-05	7.47e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—prostate cancer	1.26e-05	7.46e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB3—prostate cancer	1.26e-05	7.42e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGFR2—prostate cancer	1.25e-05	7.41e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—INS—prostate cancer	1.25e-05	7.37e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CREBBP—prostate cancer	1.22e-05	7.22e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1—prostate cancer	1.21e-05	7.13e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TERT—prostate cancer	1.2e-05	7.12e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAP2K1—prostate cancer	1.17e-05	6.89e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—AKT1—prostate cancer	1.16e-05	6.88e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CD—prostate cancer	1.16e-05	6.84e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HIF1A—prostate cancer	1.15e-05	6.8e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SERPINE1—prostate cancer	1.15e-05	6.77e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—AKT1—prostate cancer	1.14e-05	6.75e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LEP—prostate cancer	1.12e-05	6.64e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CAV1—prostate cancer	1.11e-05	6.58e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF2—prostate cancer	1.11e-05	6.55e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KDR—prostate cancer	1.1e-05	6.51e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOS3—prostate cancer	1.09e-05	6.46e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ESR1—prostate cancer	1.07e-05	6.34e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JAK2—prostate cancer	1.06e-05	6.28e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BAD—prostate cancer	1.05e-05	6.19e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MDM2—prostate cancer	1.04e-05	6.13e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—prostate cancer	1.02e-05	6.04e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—APC—prostate cancer	1.01e-05	5.99e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CG—prostate cancer	1.01e-05	5.99e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CB—prostate cancer	1.01e-05	5.96e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IRS1—prostate cancer	1e-05	5.93e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGF—prostate cancer	1e-05	5.93e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GSK3B—prostate cancer	9.73e-06	5.75e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL8—prostate cancer	9.7e-06	5.73e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—INS—prostate cancer	9.6e-06	5.67e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1B—prostate cancer	9.47e-06	5.6e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CREBBP—prostate cancer	9.41e-06	5.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1—prostate cancer	9.29e-06	5.49e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CASP3—prostate cancer	9.28e-06	5.48e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—prostate cancer	9.27e-06	5.48e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCND1—prostate cancer	9.03e-06	5.34e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAP2K1—prostate cancer	8.98e-06	5.31e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CTNNB1—prostate cancer	8.95e-06	5.29e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CD—prostate cancer	8.92e-06	5.27e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SERPINE1—prostate cancer	8.82e-06	5.21e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—prostate cancer	8.77e-06	5.18e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1A—prostate cancer	8.74e-06	5.16e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—prostate cancer	8.72e-06	5.15e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF2—prostate cancer	8.54e-06	5.05e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOS3—prostate cancer	8.42e-06	4.98e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EP300—prostate cancer	8.32e-06	4.91e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JAK2—prostate cancer	8.18e-06	4.84e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SRC—prostate cancer	8.09e-06	4.78e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MDM2—prostate cancer	7.99e-06	4.72e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—prostate cancer	7.88e-06	4.65e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—prostate cancer	7.88e-06	4.65e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT3—prostate cancer	7.8e-06	4.61e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CB—prostate cancer	7.77e-06	4.59e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL8—prostate cancer	7.47e-06	4.41e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1B—prostate cancer	7.29e-06	4.31e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—prostate cancer	7.25e-06	4.28e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFB1—prostate cancer	7.23e-06	4.27e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CASP3—prostate cancer	7.15e-06	4.23e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—prostate cancer	7.14e-06	4.22e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGFR—prostate cancer	7.09e-06	4.19e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCND1—prostate cancer	6.96e-06	4.11e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CTNNB1—prostate cancer	6.89e-06	4.07e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—prostate cancer	6.76e-06	3.99e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1A—prostate cancer	6.73e-06	3.98e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—prostate cancer	6.72e-06	3.97e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—prostate cancer	6.7e-06	3.96e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EP300—prostate cancer	6.41e-06	3.79e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SRC—prostate cancer	6.23e-06	3.68e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CA—prostate cancer	6.15e-06	3.64e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—prostate cancer	6.07e-06	3.59e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT3—prostate cancer	6.01e-06	3.55e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—prostate cancer	5.95e-06	3.52e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—prostate cancer	5.58e-06	3.3e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFB1—prostate cancer	5.57e-06	3.29e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGFR—prostate cancer	5.46e-06	3.23e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—prostate cancer	5.45e-06	3.22e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—prostate cancer	5.16e-06	3.05e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT1—prostate cancer	5.03e-06	2.97e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CA—prostate cancer	4.74e-06	2.8e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—prostate cancer	4.58e-06	2.71e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—prostate cancer	4.2e-06	2.48e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT1—prostate cancer	3.87e-06	2.29e-05	CbGpPWpGaD
